NDC 0143-1262

Lisinopril with Hydrochlorothiazide

Lisinopril And Hydrochlorothiazide

Lisinopril with Hydrochlorothiazide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Hikma Pharmaceuticals Usa Inc.. The primary component is Hydrochlorothiazide; Lisinopril.

Product ID0143-1262_203e1723-341b-49e7-a9d1-7a58155846be
NDC0143-1262
Product TypeHuman Prescription Drug
Proprietary NameLisinopril with Hydrochlorothiazide
Generic NameLisinopril And Hydrochlorothiazide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2002-07-08
Marketing End Date2023-01-18
Marketing CategoryANDA / ANDA
Application NumberANDA076265
Labeler NameHikma Pharmaceuticals USA Inc.
Substance NameHYDROCHLOROTHIAZIDE; LISINOPRIL
Active Ingredient Strength13 mg/1; mg/1
Pharm ClassesIncreased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC Exclude FlagN

Packaging

NDC 0143-1262-01

100 TABLET in 1 BOTTLE, PLASTIC (0143-1262-01)
Marketing Start Date2002-07-08
Marketing End Date2023-01-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0143-1262-05 [00143126205]

Lisinopril with Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA076265
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2002-07-08
Marketing End Date2015-03-18

NDC 0143-1262-10 [00143126210]

Lisinopril with Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA076265
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-07-08
Marketing End Date2023-01-18

NDC 0143-1262-30 [00143126230]

Lisinopril with Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA076265
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2002-07-08
Marketing End Date2015-03-18

NDC 0143-1262-01 [00143126201]

Lisinopril with Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA076265
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-07-08
Marketing End Date2023-01-18

Drug Details

Active Ingredients

IngredientStrength
HYDROCHLOROTHIAZIDE12.5 mg/1

OpenFDA Data

SPL SET ID:6573671e-3386-43d0-8f7c-bb8456bdfcbd
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197885
  • 197887
  • 197886

    • Pharmacological Class

    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]
    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]

    NDC Crossover Matching brand name "Lisinopril with Hydrochlorothiazide" or generic name "Lisinopril And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    0143-1262Lisinopril with HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0143-1263Lisinopril with HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0143-1264Lisinopril with HydrochlorothiazideLisinopril and Hydrochlorothiazide
    68788-6364Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    68788-7389Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    70518-0081Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    71335-0284Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    43353-800Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    43353-975Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    50090-2086Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    52959-997Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    66267-752Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    66267-751Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    67544-276Lisinopril with HydrochlorothiazideLisinopril with Hydrochlorothiazide
    0185-0152Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0185-0173Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0185-7100Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0378-1012Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide
    0378-2012Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide
    0378-2025Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide
    0591-0860Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0591-0861Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0591-0862Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0615-7577Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0615-7581Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    0615-7582Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    10544-236Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    10544-237Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    10544-564LISINOPRIL AND HYDROCHLOROTHIAZIDELISINOPRIL AND HYDROCHLOROTHIAZIDE
    16571-791Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    16571-792Lisinopril and HydrochlorothiazideLisinopril and Hydrochlorothiazide
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.